Magnitude Biosciences CEO David Weinkove and PhD researcher Giulia Zavagno have just had a new article published in Frontiers in Aging on how C. elegans is transforming industrial drug discovery for developing anti-ageing drugs.

This article is an open access publication accessible to readers anywhere in the world. 

For practical tips on how to overcome the challenges of developing anti-ageing drugs, please download our eBook written to help biotechs and pharma investing in anti-ageing research.